Article Text

Download PDFPDF
Barriers and enablers of adherence to high-intensity interval training among patients with cancer: a systematic review and meta-analysis
  1. Behnaz Mahdaviani1,
  2. Maryam Selk-Ghaffari1,
  3. Mojdeh Sarzaeim1,
  4. Jane S Thornton2
  1. 1Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
  2. 2Western Centre for Public Health & Family Medicine, University of Western Ontario Schulich School of Medicine and Dentistry, London, Ontario, Canada
  1. Correspondence to Dr Maryam Selk-Ghaffari; selk1360{at}gmail.com

Abstract

Objective Physical activity confers physical and psychosocial benefits for cancer patients and decreases morbidity and mortality, but adherence varies. High-intensity interval training (HIIT) is time-efficient and may improve adherence. Our aim was to determine barriers and enablers of adherence to HIIT in patients diagnosed with cancer.

Design Systematic review and meta-analysis.

Data source PubMed-MEDLINE, Scopus and Web of Science.

Eligibility criteria Intervention studies including patients diagnosed with any type of cancer, who engaged in HIIT with or without co-intervention in any stage of treatment and have reported outcomes for adherence.

Results Eight hundred articles were screened and 22 were included (n=807); 19 were included in the meta-analysis (n=755). Weighted adherence to HIIT was 88% (95% CI, 81% to 94%). None of the studies reported serious adverse events. Although being a woman and having breast cancer were associated with lower adherence (p<0.05), age was not (p=0.15). Adherence was significantly lower during the treatment phase in comparison with pre- and post-treatment phases, 83% versus 94% and 96%, respectively (p<0.001). Session time of more than 60 min, when unsupervised and combined with other interventions, was associated with decreased adherence (p<0.05).

Conclusion Adherence to HIIT programmes among cancer patients varies and is improved when the intervention is supervised, of shorter duration, consists of solely HIIT and not in combination with other exercise and occurs during pre- and post-treatment phases. Strategies to improve adherence to HIIT in specific subpopulations may be needed to ensure all patients with cancer are provided optimal opportunities to reap the benefits associated with physical activity.

PROSPERO registration CRD42023430180.

  • Exercise
  • Neoplasms
  • Exercise training
  • Physical activity
  • Meta-analysis

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

View Full Text

Footnotes

  • X @BMahdaviani, @janesthornton

  • Contributors BM and MSGh conceived the idea for the review. BM, MSGh and MS conducted search, study selection, data extraction and quality assessment. BM and MSGh conducted the analysis. BM, MSGh and JSTh conducted interpretation of data. BM, MSGH and MS drafted the initial manuscript. BM, MSGh, MS and JSTh contributed to writing the manuscript. All authors revised critically, reviewed and approved the final manuscript. MSGh is the guarantor.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests JST is an Editor of the BJSM.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.